Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

ICLR

ICON (ICLR)

ICON PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ICLR
DataHoraFonteTítuloCódigoCompanhia
05/06/202418:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ICLRICON PLC
04/06/202407:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICLRICON PLC
04/06/202407:00Business WireICON plc to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ICLRICON PLC
30/05/202409:00Business WireICON Hosts Investor Day and Updates Full Year 2024 Financial GuidanceNASDAQ:ICLRICON PLC
20/05/202407:00Business WireICON plc to hold Investor Day Meeting on May 30, 2024NASDAQ:ICLRICON PLC
09/05/202407:30Business WireICON releases its ICON Cares 2023 ReportNASDAQ:ICLRICON PLC
30/04/202417:55Business WireICON Announces Pricing of USD 2 Billion NotesNASDAQ:ICLRICON PLC
24/04/202417:15Business WireICON Reports First Quarter 2024 ResultsNASDAQ:ICLRICON PLC
03/04/202417:15Business WireICON Announces CFO TransitionNASDAQ:ICLRICON PLC
25/03/202417:15Business WireICON plc Schedules First Quarter 2024 Earnings Conference CallNASDAQ:ICLRICON PLC
26/02/202418:15Business WireICON plc to Present at Upcoming Investor ConferencesNASDAQ:ICLRICON PLC
21/02/202418:15Business WireICON Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:ICLRICON PLC
30/01/202414:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ICLRICON PLC
30/01/202408:00Business Wire ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference CallNASDAQ:ICLRICON PLC
24/01/202409:00Business WireNew ICON Survey Highlights Importance of Combination Therapies in Future Obesity TreatmentNASDAQ:ICLRICON PLC
09/01/202410:00Business WireICON Issues Financial Guidance for Full Year 2024NASDAQ:ICLRICON PLC
08/01/202409:00Business WireBiotech companies to increase R&D spend but highlight complexity of clinical trials - ICONNASDAQ:ICLRICON PLC
04/01/202409:00Business WireICON plc to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ICLRICON PLC
18/12/202309:15Business WireICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023NASDAQ:ICLRICON PLC
07/12/202318:15Business WireICON Secures Upgraded Credit Rating from Moody’s Investors ServiceNASDAQ:ICLRICON PLC
25/10/202317:15Business WireICON Reports Third Quarter 2023 ResultsNASDAQ:ICLRICON PLC
12/10/202310:07Business WireICON Secures Upgraded Credit Rating from S&P Global RatingsNASDAQ:ICLRICON PLC
21/09/202307:00Business WireICON plc Schedules Third Quarter 2023 Earnings Conference CallNASDAQ:ICLRICON PLC
20/09/202308:15Business WireICON Releases Expanded End-to-end Clinical Trial Tokenisation SolutionNASDAQ:ICLRICON PLC
13/09/202308:15Business WireBARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical TrialNASDAQ:ICLRICON PLC
06/09/202307:00Business WireICON plc to Present at the Baird Global Healthcare ConferenceNASDAQ:ICLRICON PLC
26/07/202317:20Business WireICON Shareholders Vote in Favour of All Resolutions at its Annual General MeetingNASDAQ:ICLRICON PLC
26/07/202317:15Business WireICON Reports Second Quarter 2023 ResultsNASDAQ:ICLRICON PLC
13/07/202308:15Business WireFirst Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital ServicesNASDAQ:ICLRICON PLC
27/06/202317:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ICLRICON PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:ICLR